Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optimization of Smoking Cessation Strategies in Cancer Patients
NCT02048917Phase 1Completed
- Sponsor
- University of Kentucky
- Start
- Jul 2014
- Primary completion
- May 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of varenicline, bupropion and nicotine in Tobacco Use Disorder (TUD) (12 arms), sponsored by University of Kentucky. Primary endpoint: Cigarette use at 8 weeks. Started Jul 2014; status: completed.
02
Drugs
vareniclinebupropionnicotine
03
Conditions
Tobacco Use Disorder (TUD)
Beyond the preview
Go deeper on NCT02048917.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02048917.